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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYDegeneration of basal forebrain cholinergic neurons (BFCNs) is associated with cognitive impairments of Alzheimer’s disease (AD),
implying that BFCNs hold potentials in exploring stem cell-based replacement therapy for AD. However, studies on derivation of BFCNs
from embryonic stem cells (ESCs) are limited, and the application of ESC-derived BFCNs remains to be determined. Here, we report on
differentiation approaches for directing both mouse and human ESCs into mature BFCNs. These ESC-derived BFCNs exhibit features
similar to those of their in vivo counterparts and acquire appropriate functional properties. After transplantation into the basal forebrain
of AD model mice, ESC-derived BFCN progenitors predominantly differentiate into mature cholinergic neurons that functionally inte-
grate into the endogenous basal forebrain cholinergic projection system. The AD mice grafted with mouse or human BFCNs exhibit
improvements in learning and memory performances. Our findings suggest a promising perspective of ESC-derived BFCNs in the devel-
opment of stem cell-based therapies for treatment of AD.INTRODUCTION
Alzheimer’s disease (AD) is the most devastating neurode-
generative disorder (Tanzi and Bertram, 2005) and is char-
acterized by progressive decline in cognitive functions
(Bertram et al., 2010; LaFerla et al., 2007). The basal fore-
brain cholinergic system, including the nucleus basalis of
Meynert (NBM), the horizontal and vertical diagonal
bands of Broca, and the medial septal nucleus, provides
the primary source of cholinergic innervation to the cere-
bral cortex, hippocampus, and amygdala (Mesulam et al.,
1983) and plays critical roles in the processing of infor-
mation related to cognitive function (Fodale et al.,
2006). The degeneration and loss of cholinergic neurons
and synapses throughout the basal forebrain, especially
in the NBM, provides a pathological substrate for cholin-
ergic deficiency in the brain of AD patients (Morrison and
Hof, 1997). The early and progressive cholinergic defi-
ciency of basal forebrain cholinergic neurons (BFCNs),
characterized by a reduction in acetylcholine (ACh) syn-
thesis, contributes substantially to the gradual cognitive
decline of AD patients (Fisher, 2008; Perry et al., 1999).
These studies imply that the transplantation of BFCNs
might functionally restore cholinergic innervation in
the basal forebrain of AD patients and repair cognitive
impairments. Thus, the BFCNs hold potential in devel-776 Stem Cell Reports j Vol. 5 j 776–790 j November 10, 2015 j ª2015 Theoping stem cell-based replacement therapy for the treat-
ment of AD.
Embryonic stemcells (ESCs) or their derivatives, especially
ESC-derived subtype-specific and functionally integrated
neurons, have been proposed as promising therapies for
neurodegenerative diseases (Lindvall and Kokaia, 2006;
Lindvall et al., 2004). Assays that direct efficient differentia-
tion ofmouse and human ESCs into dopaminergic neurons
have been established, and ESC-derived dopaminergic neu-
rons were shown to correct functional deficits in animal
models of Parkinson’s disease (Kim et al., 2002; Kirkeby
et al., 2012; Kriks et al., 2011; Yang et al., 2008). However,
the mechanisms underlying BFCN generation in vivo are
notwell characterized.There is therefore a lackof knowledge
on how to direct BFCN generation from ESCs in vitro. To
date, the directed differentiation of BFCNs from mouse
ESCs has not been achieved, and studies exploring the gen-
eration of BFCNs from human ESCs have emerged only
recently. One report has used diffusible ligands, including
retinoic acid (RA), to selectively direct the differentiation
ofhumanESCs intoBFCNswithanundefined regional iden-
tity (Bissonnette et al., 2011). Another study has demon-
strated the generation of equal proportions of BFCNs and
GABAergic interneurons from human ESC-derived medial
ganglionic eminence (MGE)-like progenitors (Liu et al.,
2013). Because the region-specific differentiation fromAuthors
Figure 1. Efficient Derivation of BFCNs from Mouse ESCs
(A) Top: schematic representation of the methods used to direct the differentiation of mouse ESCs (mESCs) into BFCNs. Bottom: gene
expression heatmap for different marker genes at the time indicated. The value indicates the log2-transformed fold change (relative to
Gapdh and normalized to the highest value).
(B) Left: immunocytochemistry analysis of NKX2.1 and OTX2 expression in mouse EBs at day 8. Right: quantification of the data in the left
panel.
(legend continued on next page)
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ESCs tobasal forebrain,especially toBFCNs, isnotwell estab-
lished, efforts to explore the possibility of stem cell-based
therapies for AD have mainly used other types of cells,
such as adult neural stem cells (Blurton-Jones et al., 2009),
ESC-derived neural precursor cells (Moghadam et al.,
2009), human umbilical cord blood-derived mesenchymal
stem cells (MSCs) and bone marrow-derived MSCs (Lee
et al., 2010a, 2010b), astrocytes (Pihlaja et al., 2008), and
sonic hedgehog (SHH)/RA-induced progenitors of ChAT+
neurons (Moghadam et al., 2009). These cells have been
transplanted into the hippocampus of AD animal models
anddemonstrated to rescuememory deficits of these ADan-
imals. The functional properties of human ESC-derived
BFCNs have been investigated after transplantation into
murine hippocampal slice cultures (Bissonnette et al.,
2011) or into severe combined immunodeficiency mice
with a destroyed medial septum by muP75-saporin but not
into AD model mice (Liu et al., 2013). Thus, it remains
unknown whether mouse or human ESCs can efficiently
differentiate into BFCNs and whether mouse and human
ESC-derived BFCNs can restore cholinergic function and
alleviate cognitive deficits in AD transgenic mice.
Here, we develop a differentiation approach that directs
both mouse and human ESCs into mature and functional
BFCNs. The differentiation process recapitulates all key fea-
tures of BFCN specification in vivo and goes through a
BFCN progenitor stage. The ESC-derived BFCN progenitors
are transplanted into the basal forebrain, where the in vivo
BFCNs are situated, of transgenic AD mice. Two months
later, the transplanted BFCN progenitors are found to pre-
dominantly differentiate into mature cholinergic neurons
that functionally integrate into the endogenous cholin-
ergic projection system of these AD mice. Furthermore,
these AD model mice show improved cognitive abilities
upon transplantation.RESULTS
Efficient Derivation of BFCNs from Mouse ESCs
Both SHH and bone morphogenetic protein 9 (BMP9) sig-
nals have been reported to play critical roles in specification
and development of BFCNs during mouse neurogenesis
(Dessaud et al., 2008; Lo´pez-Coviella et al., 2000; Reilly(C) Left: double immunocytochemistry analysis of ChAT and NEUN expr
(D) Percentages of different subtypes of neurons among total cells o
(E) Double immunocytochemistry analysis of ISL1 and HB9 expressio
(F) Quantification of the data in (E).
(G) Double immunocytochemistry analysis of ISLl or NKX2.1 with ChA
(H) Quantification of the data in (G).
Scale bars, 50 mm (B, C, E, G). n = 3 independent experiments; two-t
Related to Figure S1.
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sequential treatment with SHH and BMP9 in our serum-
free, floating embryoid body (EB) system and finally estab-
lished amethod that allows efficient and preferential differ-
entiation of mouse ESCs into BFCNs (Figure 1A). The pro-
gressive neural commitment from mouse ESCs to BFCNs
was characterized bymeasuring themRNA levels of various
marker genes. While the expression of the pluripotency
genes Rex1 andOct4 decreased, the expression of the neural
progenitor markers Sox1 and Pax6 increased and reached
their peak level at day 4. This was followed by the highest
expression of the ventral anterior forebrain progenitor
markers Foxg1,Otx2,Nkx2.1, and Six3 around day 8. Finally,
the expression of the neuronal markers Tuj1 and NeuN,
together with the BFCN marker genes Nkx2.1, Lhx8, Isl1,
ChAT, and P75, increased around days 12–14 (Figure 1A).
Immunostaining analysis confirmed the neural fate
commitment of mouse ESCs and showed that most cells
in the day-8 EBs were SOX1+ and NESTIN+ neural progeni-
tors, while OCT4+ pluripotent cells were barely detectable
at day 8, and TUJ1+ immature neurons started to emerge
at theborder of EBs (Figure S1A).Ahighpercentageofneural
progenitors in day-8 EBs exhibited a ventral telencephalic
identity by expressing the ventral telencephalic marker
NKX2.1 and the anterior forebrain neuroectoderm marker
OTX2 (Figure 1B). During mouse neurogenesis, BFCNs
derive from the NKX2.1+ ventral telencephalic progenitors,
and continuous expression of Nkx2.1 is essential for the
maturation and maintenance of this subtype of neurons
(Magno et al., 2011; Sussel et al., 1999). Most NKX2.1+
ventral telencephalic progenitors are KI67+ dividing cells
in day-8 EBs (Figure S1B). Because the sequential treatment
withSHHandBMP9promoted the cholinergic fate commit-
ment of NKX2.1+ ventral telencephalic progenitors, the
generation of ChAT+ cholinergic neurons significantly
increased compared with cultures without these factors,
and most NEUN+ mature neurons were ChAT+ cholinergic
neurons at day 14 (Figure 1C). In addition, the ChAT+
cholinergic neurons (37%)were predominant in our system
compared with other subtypes of neurons, such as
VGLUT1/2+ glutamatergic neurons (11.5%), GAD67+
GABAergic neurons (1.7%), and TH+ dopaminergic neurons
(2%) (Figure 1D and Figure S1C). This was confirmed by the
mRNA expression of corresponding subtype marker genesession on day 14. Right: quantification of the data in the left panel.
n day 14.
n on day 10.
T and VAChT on day 12.
ailed t test. All data are presented as the mean ± SD. *p < 0.05.
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(Figure S1D). Then, ISL1/HB9 double immunostaining, a
classical assay to distinguish the two major types of cholin-
ergic neurons in the mammalian CNS (Woolf, 1991), was
performed to determine whether ChAT+ cholinergic neu-
rons are ISL1+/HB9 BFCNs of basal forebrain identity or
ISL1+/HB9+ motor neurons of spinal cord identity. The
ISL1/HB9 double staining was validated in the forebrain
and spinal cord of E12.5 mouse embryos (Figure S1E). With
the SHHandBMP9 treatment, almost allmouse ESC-derived
ISL1+ cells were HB9 BFCNs, and the HB9+ cells were barely
detected on day 10 (Figures 1E and 1F). In contrast, the SHH
and RA treatment mainly induced ISL1+/HB9+ motor
neuron-like cells (Figures 1E and 1F), which was consistent
with previous reports (Wichterle et al., 2002).Double immu-
nocytochemistry analysis for ISL1 or NKX2.1 with ChAT or
VAChTshowedthatapproximatelyhalfofChAT+orVAChT+
neurons expressed ISL1 or NKX2.1 on day 12 (Figures 1G
and 1H), indicating that a relatively high percentage of
SHH/BMP9-induced cholinergic neurons possessed a basal
forebrain identity. Consistently, the expression of Isl1,
Nkx2.1, and the anterior marker gene Six3 increased and
the expression of the posterior markers HB9, En2, Gbx2,
andHoxb9 decreased on day 12 (Figure S1F). Taken together,
wehaveestablished amethod that directs region-specificdif-
ferentiation from mouse ESCs to basal forebrain. Following
our approach, the mouse ESCs mainly give rise to NKX2.1+
ventral telencephalic progenitors that predominantly differ-
entiate into BFCNs. The differentiation process recapitulates
the expression dynamics of key marker genes during BFCN
specification and via a BFCN progenitor stage.
Mouse ESC-Derived BFCNs Are Mature and Functional
In Vitro
To test whether themouse ESC-derived BFCNs acquired the
ability to synthesize and hydrolyze ACh, we cultured these
cells for 16 days and then measured the concentration of
secreted ACh and activity of acetylcholinesterase (AChE)
by ELISA. The data showed that the SHH and BMP9 treat-
ment significantly increased ACh secretion, as well as
AChE activity, comparedwith control cells (Figure 2A), sug-Figure 2. Characterization of Membrane Properties Mouse ESCs-D
(A) Quantification of ACh and AChE by ELISA analyses for mouse ESC
(B) Left: representative traces of no AP (upper), one AP (middle), and
16 (group I) and days 20–22 (group II). Right: percentages of group
(C) Representative traces showing EPSPs and IPSPs received by group
(D) Percentages of cells in group I or II receiving EPSPs or IPSPs.
(E) Left: representative differential interference contrast and fluores
tative traces showing that group II neuron cells formed synaptic con
APs.
(F) Representative fluorescent images (left) and dual recording traces
Scale bars, 25 mm (E, F). n = 3 biological replicates; two-tailed t test
Related to Figure S2 and Table S1.
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functions to their counterparts in vivo in regards to the
metabolism of ACh.
Whole-cell patch-clamp recordings were performed on
randomly picked SHH- andBMP9-treated neurons differen-
tiating for 15–16days (n=37, group I) or 20–22days (n=42,
group II) from mouse ESCs, respectively. More than half of
the cells in each group fired action potentials (APs) contin-
uously in response to the 500ms step currents, and approx-
imatelyone fourthof the recordedneuroncells fired a single
AP (Figure 2B). The mouse ESC-derived neurons displayed
remarkable panoply of biophysical cellular profiles
in vitro (Table S1). In addition, the group II neurons showed
more hyperpolarized resting membrane potential,
increased AP amplitude, and decreased AP half-width
compared with group I neurons (Table S1). More than half
of the neurons in group II expressed both excitatory post-
synaptic potentials (EPSPs) and inhibitory postsynaptic
potentials (IPSPs), while the percentages of EPSP- and
IPSP-expressing cells in group I were much lower (Figures
2C and 2D), indicating that functional synaptic connec-
tions formed among the mouse ESC-derived neurons in a
time-dependent manner. Paired whole-cell recordings on
neurons from groups I and II successfully detected the post-
synaptic responses that were triggered by presynaptic APs
(Figure 2E) and the electrical synaptic connections between
neurons (Figure 2F). Together, these data suggested that
ESC-derived BFCNs possessedmembrane properties similar
to those of mature and functional neurons in vivo.
The same protocol allowed the predominantly neural dif-
ferentiation of mouse induced pluripotent stem cells
(iPSCs) into ChAT+ cholinergic neurons (Figures S2A and
S2B). Whole-cell recordings showed that the mouse iPSC-
derived cholinergic neurons possessed functional mem-
brane properties similar to those of neurons in vivo, such
as APs and spontaneous postsynaptic currents (Figure S2C).
Taken together, the mouse ESC-derived BFCNs can secrete
ACh, fire APs, form mature pre- and postsynaptic speciali-
zations, and display appropriate electrophysiological prop-
erties in vitro.erived BFCNs
(mESC)-derived BFCNs at day 16.
continuous AP (lower) from mESC-derived neuron cells on days 15–
I or II cells expressing different types of AP.
I and II neuron cells.
cent images showing dual whole-cell recordings. Right: represen-
nections. Arrowheads indicate single EPSPs evoked by presynaptic
(right) showing that the mouse neurons formed electrical synapses.
. Data are presented as the mean ± SD. *p < 0.05.
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Transplanted Mouse ESC-Derived BFCN Progenitors
Predominantly Differentiate into Cholinergic
Neurons in the Basal Forebrain of the ADModelMouse
To study whether ESC-derived BFCNs can function in vivo
and replace lost neurons in diseased mice, we transplanted
mouse ESC-derived BFCN progenitors into the NBM of two
strains of transgenic AD model mice: 5XFAD and APP/PS1.
Both AD model mice can recapitulate major neuropatho-
logical features of AD, especially the AD amyloid pathol-
ogy, and development of AD symptoms, such as cognitive
deficits (Jankowsky et al., 2004; Oakley et al., 2006). Before
transplantation, we examined the neuropathological pro-
cesses of AD mice by measuring the levels of Ab deposits
in the brain. Consistent with previous studies (Jankowsky
et al., 2004; Oakley et al., 2006), the Ab plaques in the brain
of 5XFAD mice appeared in the subiculum and deep layers
of the cortex as early as 2 months of age and accumulated
robustly within most regions of the brain, including the
NBM at 3 to 4 months of age (Figure S3A). In APP/PS1
mice, the deposited amyloid did not appear until 6 months
of age and began to spread intomost regions of the brain at
9 months of age (Figure S3B). We chose to perform cell
transplantations at the age when each strain exhibits dra-
matic amyloid plaque but does not show detectable neuron
degeneration or cognitive deficits (Jankowsky et al., 2004;
Oakley et al., 2006), which is 4 months of age for 5XFAD
mice and 10 months for APP/PS1 mice.
To trace the transplanted cells in vivo, day-8 BFCN pro-
genitors derived from EGFP-labeled mouse ESCs (Adams
et al., 2003) were used in this experiment and thereafter.
The proliferation and differentiation ofGFP+ BFCNprogen-
itors in the brain of 5XFADmice weremeasured at different
periods, such as 2 weeks, 1 month, 2 months, 3 months,
and 6months after transplantation.We found that the pro-
liferation of grafted BFCN progenitors decreased gradually
with the disappearance of KI67+ cells while the neuronal
differentiation among these grafted cells increased with
the appearance of NEUN+ neurons (Figure S3C). Two
months after transplantation, the proliferating cells among
the grafted cells were seldom detected, and most cells
among the grafted cells were NEUN+ neurons (Figure S3D),
indicating that 2 months are sufficient and necessary for
the neuronal differentiation of grafted BFCN progenitors.
Thus, the grafted BFCN progenitors were kept for 2months
in the brain of AD mice in the following experiments.
The bilateral transplantation was performed by the injec-
tion of 80,000 EGFP+ cells into each NBM of AD mice
brains. Two months later, the AD mice were subjected to
a behavior test. After the behavior test, the numbers of
EGFP+ cells were counted. Among 42 analyzed mice,
including both 5XFAD and APP/PS1 mice, 33 mice had
numbers of EGFP+ cells ranging from 60,000 to 80,000
per NBM, 4 mice had fewer than 60,000 EGFP+ cells, andStem Cell R5 mice had a little more than 80,000 EGFP+ cells, showing
that the average survival rate of transplanted cells is 75%.
There was no detectable sign of tumor formation in host
brains grafted with BFCN progenitor cells in the NBM.
Among both strains of ADmice grafted with mouse ESC-
derived BFCN progenitor cells, approximately 80% of the
surviving EGFP+ cells remained in the NBM to which
they were originally delivered (Figures 3A and 3B and Table
S2). The characterization of surviving EGFP+ cells in the
NBM by immunostaining showed that approximately
75% of the EGFP+ cells were NEUN+ neurons, less than
15% of the EGFP+ cells differentiated into GFAP+ astrocytes
and O4+ oligodendrocytes, and only a few EGFP+ cells ex-
pressed the neural progenitor cell marker NESTIN (Figures
3C and 3E), indicating that most transplanted BFCN pro-
genitors had differentiated into mature neurons in the
NBM of the host brain. In addition, approximately 50%
of the EGFP+ cells were ChAT+ cholinergic neurons (Figures
3D and 3E). The number of GAD67+ GABAergic or
VGLUT1/2+ glutamatergic neurons was much lower than
that of ChAT+ neurons (Figures 3D and 3E). Lastly, we
measured the concentration of secreted ACh and the activ-
ity of AChE in the brain of 5XFAD mice with or without
grafted BFCN progenitors by ELISA. We found that both
the ACh secretion and the AChE activity significantly
increased in the brain of 5XFAD mice with BFCN progeni-
tors compared with the brain of 5XFAD mice without
BFCN progenitors (Figure 3F). Together, these data indicate
that the transplanted BFCN progenitors survive well in the
NBM and can predominantly differentiate into mature
cholinergic neurons in the basal forebrain of host AD
mice. The mouse ESC-derived BFCNs exhibited functional
properties thatwere characteristic ofmature BFCNs in vivo.
Mouse ESC-Derived Neurons Functionally Integrate
into the Endogenous Cholinergic Projection System
of the AD Mouse
Previous studies indicated that reconstruction of lost
neuronal circuitry may be an important prerequisite for
the restoration of neural function in impaired brain regions
(Lindvall and Kokaia, 2006; Lindvall et al., 2004). We thus
sought to explore the electrophysiological properties and
migration or integration of transplanted cells within the
basal forebrain of both 5XFAD and APP/PS1 mice. After
the behavior test, 200-mm-thick brain slices containing
transplanted cells were prepared for whole-cell recording.
Altogether, 18 EGFP+ cells in the basal forebrain of
5XFAD or APP/PS1 mice were recorded, and subsequent
immunohistochemistry confirmed that more than half of
them (13/18) were ChAT+ cholinergic neurons (Figure 4A).
Among these cells, 15 cells fired repetitive APs (Figure 4B),
indicating that they possessed membrane properties of
mature neurons. In addition, these 15 neuronal cellseports j Vol. 5 j 776–790 j November 10, 2015 j ª2015 The Authors 781
Figure 3. Differentiation of Mouse ESC-Derived BFCN Progenitors 2 Months after Transplantation into the NBM of AD Model Mice
(A) As shown on the coronal brain section of AD mice, most surviving EGFP+ BFCN progenitors were found in the NBM.
(B) Schematic diagram of the distribution of EGFP+ BFCN progenitors shown in (A).
(C) EGFP fluorescence and immunocytochemistry analyses of NEUN or GFAP expression in the NBM of the host brain.
(D) EGFP fluorescence and immunocytochemistry analyses of ChAT or GAD67 expression in the NBM of the host brain.
(E) Quantification of the data in (C) and (D).
(F) Quantification of ACh and AChE by ELISA analyses in the 5XFAD brain 2 months after transplantation (n = 10).
Scale bars, 1 mm (A) and 25 mm (C and D). n = 3 biological replicates; two-tailed t test. Data are presented as the mean ± SD. *p < 0.05.
Related to Figure S3.
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Figure 4. Mouse ESC-Derived Cholinergic Neurons Functionally Integrated into the Basal Forebrain of Host Mice
(A) Representative recorded cells labeled by Avidin-PE (a, red). Arrows indicate recorded cells involved in a basal cholinergic projection
system. No. 1, 2, and 3 recorded cells were EGFP+ (b), Avidin-PE+ (c), and ChAT+ (d), respectively, and appear in overlay images with these
indicated markers (e).
(B) No. 1–3 EGFP+/ChAT+ cholinergic neurons fired continuous APs.
(C and D) No. 3 cholinergic neuron received functional synaptic inputs, as reflected by the occurrence of EPSCs (C) and IPSCs (D).
(E) No. 4 neuron in the basal forebrain displayed a long axon projecting along the NBM.
(legend continued on next page)
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exhibited a more hyperpolarized resting membrane poten-
tial and AP threshold, lower input resistance, higher
cellular capacitance, increased AP amplitude, and
decreased AP half-width compared to the recorded neurons
differentiated in vitro (Table S1), suggesting that in vivo
differentiated cholinergic neurons were functionally
mature and the basal forebrain of host mice might provide
a favorable environment for the differentiation of trans-
planted cells into mature neurons. Most recorded neurons
(15/18) exhibited excitatory and inhibitory synaptic activ-
ities (Figures 4C and 4D). The average frequencies of the
miniature excitatory postsynaptic current (EPSC) and
spontaneous inhibitory postsynaptic current (IPSC) were
4.8 ± 0.5 and 1.3 ± 0.1 Hz, respectively, indicating that
the ChAT+ neurons were functionally integrated into the
endogenous neuronal circuitry system andhadmaintained
functional activity in vivo for up to 10 weeks after trans-
plantation. After the EGFP+ cells were recorded, post hoc
immunohistochemistry was performed to trace the projec-
tion and migration of EGFP+ cells. Most recorded EGFP+
cells (14/18) showed the typical projection pattern of neu-
rons of the basal nucleus, characterized by their axon-
dendrite orientation, and axon projections up to 700 mm
in length were detected (Figure 4E). Besides the recorded
cells, most examined EGFP+ cells projected or migrated
along cholinergic projections throughout the NBM, from
the bottom to the NBM tip or NBM isthmus and toward
the cortex and hippocampus (Figure 4F and Table S2), indi-
cating that transplanted cells or their progeny morpholog-
ically incorporated into the endogenous cholinergic pro-
jection system. In addition to whole-cell recording,
electron microscopy using immunogold labeling anti-GFP
antibody was performed. We observed typical synaptic
structures between the green BFCN progenitor-derived
neuron cell (pseudocolor green) and the endogenous
neuron cell (pseudocolor yellow) (Figure S4A), which is
indicative of the synapse formation between exogenous
neurons and host neurons. Together, these data demon-
strate that themouse ESC-derived BFCNs functionally inte-
grate into the endogenous basal forebrain neuronal cir-
cuitry and cholinergic projection system of both 5XFAD
and APP/PS1 AD mice.
The correct connections between the grafted cells and
the endogenous neurons were believed to be essential to
the symptomatic relief of AD mice. In addition to the inte-
gration, trophic factor secretion andAb clearance caused by(F) The track of migration or projection of transplanted EGFP+ BFCN
projected along the endogenous NBM cholinergic projection track, wh
nucleus to the hippocampus. Close-ups of the outlined region in (a) sh
endogenous and exogenous cholinergic neurons (c), nuclei stained w
Scale bars, 50 mm (Aa, F), 10 mm (Ab–Ae), and 200 mm (E).
Related to Figure S4 and Tables S1 and S2.
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ery of AD mice (Blurton-Jones et al., 2009; Lee et al.,
2010a, 2010b; Pihlaja et al., 2008) . After the behavior
test, we measure the levels of trophic factor BDNF and Ab
in the brain of 5XFAD mice with and without grafted
BFCN progenitors. We found that levels of BDNF in
5XFAD mice with BFCN progenitors were significantly
increased compared to those in 5XFAD mice without
grafted cells (Figure S4B). The level of Ab plaques in the
brain of 5XFAD mice was measured by quantifying the
Ab plaque number and burden. The results showed that
Ab plaques between 5XFAD mice with and those without
BFCN progenitors were similar (Figure S4C). These data
indicate that the transplanted BFCN progenitors induce
the secretion of trophic factors but do not alter the global
level of Ab plaques in the host brain.
Human ESCs Efficiently Differentiate into Mature
and Functional BFCNs In Vitro and In Vivo
After successfully generating BFCNs from mouse ESCs, we
sought to generate BFCNs from human ESCs. To this end,
we tried different dosages and time points of SHH and
BMP9 treatment and developed the most effective
approach for human ESCs (Figure 5A). During human
ESC neural differentiation, the expression of OCT4
decreased first and the expression of the neural epithelial
markers PAX6 and then SOX1 increased substantially there-
after (Figure 5A). The addition of SHHdecreased the expres-
sion of PAX6 and increased SOX1 expression continuously
(Figure 5A). Most cells in day-26 neurospheres were SOX1+
and NESTIN+ neural progenitors (Figure S5A), and more
than half of day-26 neural progenitors were NKX2.1+/
OTX2+ BFCN progenitors (Figure 5B). In addition, most
NKX2.1+ BFCN progenitors were KI67+ dividing cells (Fig-
ure S5B). The expression of ChATwas dramatically induced
by sequential treatment with SHH and BMP9, similar to
that of NEUN (Figure 5A). At day 40, more than half of
the NEUN+ cells were VAChT+ mature cholinergic neurons
(Figure 5C). Similar to themouse ESC BFCNdifferentiation,
human ESCs predominantly differentiated into VAChT+
cholinergic neurons (38%) in our culture system and rarely
into other neuronal subtypes (Figure 5D and Figure S5C),
which was confirmed by the mRNA expression of subtype
marker genes (Figure S5D). On day 35, almost all human
ESC-derived ISL1+ cholinergic neurons were HB9 BFCNs
and few HB9+ cells were observed (Figures 5E and 5F). Onprogenitors in the NBM. Transplanted EGFP+ cells (a) migrated or
ich is long and regular, representative of the projection from basal
ow EGFP+ exogenous BFCN progenitors and their progeny (b), ChAT+
ith DAPI (d), and overlay images (e).
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Figure 5. Efficient Derivation of BFCNs from Human ESCs
(A) Top: schematic representation of the method used to direct the differentiation of human ESCs (hESCs) into BFCNs. Bottom: qPCR
analysis of the expression level of different marker genes at the time indicated.
(B) Left: immunocytochemistry analysis of NKX2.1 and OTX2 expression in human neurospheres at day 26. Right: quantification of the data
in the left panel.
(C) Left: double immunocytochemistry analysis of VAChT and NEUN on day 40. Right: quantification of the data in the left panel.
(D) Percentages of different subtypes of neurons among total cells on day 40.
(legend continued on next page)
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day 40, more than half of human ESC-derived ChAT+ or
VAChT+ neurons were ISL1+ or NKX2.1+ BFCNs (Figures
5G and 5H). This was confirmed by the increased expres-
sion of anterior ventral marker genes and the decreased
expression of posterior marker genes (Figure S5E). On day
40, the SHH/BMP9-induced human neurons secreted a
higher level of ACh and showed higher AChE activity
than did control cells (Figure S5F). On day 65, 30 SHH/
BMP9-induced neuron cells were randomly picked and
measured by whole-cell patch-clamp recordings, and
most of them (23/30) were mature neurons that fired APs
(Figure S5G). In addition, approximately half of the neu-
rons expressing continuous AP (7/15) exhibited sponta-
neous postsynaptic currents. These neurons also expressed
the synaptic marker SYNAPSIN (Figure S5H). Together,
these data indicate that human ESCs, like mouse ESCs, pre-
dominantly give rise to mature and functional BFCNs
through a BFCN progenitor stage in our culture system.
Similar to the bilateral transplantation with mouse ESC-
derived BFCNs described earlier, 80,000 human ESC-derived
BFCN progenitors were transplanted into each NBM of
5XFADADmodelmice. Immunostaining forhumannuclear
protein (hNuclei) indicated that the transplanted human
cells survived and migrated within the mouse NBM after
the behavior test, which was 7 weeks after transplantation
(Figure S6A). Among 11 analyzedmice, the average number
of surviving hNuclei+ human cells in each NBM was 6,000.
Double immunostaining showed that approximately 60%
of these surviving hNuclei+ cells were NEUN+ mature neu-
rons and less than 10% of human cells differentiated into
GFAP+ astrocytes or OLIGO+ oligodendrocytes (Figure S6B).
Among thehumancells, approximately20%of thehNuclei+
cells were cholinergic neurons, expressing both ChAT and
VAChT (Figure S6C). The GAD67+ GABAergic or VGLUT1/
2+ glutamatergic neurons among hNuclei+ cells were not de-
tected. Together, these data indicate that the transplanted
human BFCN progenitor cells can survive in the NBM and
predominantly differentiate into cholinergic neurons in
the basal forebrain of host ADmice.
Transplanted Mouse and Human ESC-Derived BFCN
Progenitors Ameliorate the Cognitive Decline of AD
Model Mice
To assess cognitive function, particularly the spatial
learning and reference memory abilities of 5XFAD and
APP/PS1 mice with transplanted mouse ESC-derived(E) Double immunocytochemistry analysis of ISL1 and HB9 on day 35
(F) Quantification of the data in (E).
(G) Double immunocytochemistry analysis of ISLl or NKX2.1 with ChA
(H) Quantification of the data in (G).
Scale bars, 50mm(B, E, G) and25mm(C). n = 3 independent experiments
Related to Figures S5 and S6.
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was performed 2 months after transplantation. For each
strain of AD model mice, four groups of mice were sub-
jected to MWM: AD mice with transplanted ESC-derived
BFCN progenitors (referred to as BFCN mice), AD mice
receiving vehicle (sham) injections, age-matched AD
mice, and wild-type mice. In a control experiment
involving a visible platform, all groups of mice showed
no differences in the speed and latency period to locate
the platform, and the transgenic modification or cell trans-
plantation had no effect on sensorimotor or motivational
performance. Spatial learning abilities were assessed by
escape latency toward a hidden platform. Intriguingly,
both strains ofmicewithmouse ESC-derived BFCNprogen-
itors exhibited gradually and significantly shorter escape la-
tencies compared to their corresponding sham control and
AD control, respectively, and BFCN mice showed a steady
improvement in learning (Figures 6A and 6B). The perfor-
mance of the ADmice transplanted with BFCN progenitors
was comparable to that of wild-type mice in learning
training, and vehicle delivery had no effect on the learning
performance of AD mice (Figures 6A and 6B). These data
indicate that transplanted mouse ESC-derived BFCN pro-
genitors rescued the learning deficits of ADmice. The probe
test was performed 24 hr after the final learning trial on day
7 to assess the spatial memory ability of these mice. Both
5XFAD-BFCN and APP/PS1-BFCN mice spent a signifi-
cantly longer time in the target quadrant and showed a
greater number of platform-site crossovers than the AD
and sham-controlmice, indicating that the spatialmemory
decline of AD mice was ameliorated by transplantation of
mouse ESC-derived BFCN progenitors (Figures 6C and 6D).
5XFADmice grafted with human ESC-derived BFCN pro-
genitorswere also subjected tobehavior assays. Sixweeks af-
ter transplantation, 5XFAD mice with human ESC-derived
BFCN progenitors also showed improvement in learning
(Figure 6E) and memory (Figure 6F) abilities. Taken
together, these results indicate that the cognitive deficiency
ofADmodelmice canbe rescuedby transplantationof both
mouse and human ESC-derived BFCN progenitors.DISCUSSION
In this study, we established an approach that efficiently
directed both mouse and human ESCs into mature and.
T and VAChT on day 40.
; two-tailed t test. All data are presented as themean± SD. *p < 0.05.
Authors
Figure 6. Transplantation of Mouse or
Human BFCN Progenitors Rescues the
Cognitive Impairments of AD Model Mice
(A and B) Training trials revealed that
5XFAD mice (A) and APP/PS1 mice (B)
grafted with mouse ESC (mESC)-derived
BFCN progenitors exhibited significantly
shorter escape latencies from day 5
compared to sham controls and transgenic
controls and performed as well as wild-type
controls.
(C and D) In the probe test, 5XFAD mice (C)
and APP/PS1 mice (D) grafted with mESC-
derived BFCN progenitors spent signifi-
cantly longer amounts of time in the target
quadrant and had a greater number of target
crossings compared to both sham controls
and transgenic controls.
(E) Training trials revealed that 5XFAD mice
with human ESC (hESC)-derived BFCN pro-
genitors exhibited significantly shorter
escape latencies from day 4 compared to
controls.
(F) The probe test revealed that the 5XFAD
mice with hESC-derived BFCN progenitors
spent longer amounts of time in the target
quadrant and had a greater number of target
crossings compared to controls.
n = 3 independent experiments; two-way
ANOVA test. Results are presented as
mean ± SD. *p < 0.05.functional BFCNs. The differentiation process recapitu-
lated expression dynamics of key factors involved in
BFCN development in vivo and went through a BFCN pro-
genitor stage. After transplantation into the basal forebrain
of AD transgenic mice, the ESC-derived BFCN progenitors
predominantly differentiated into mature cholinergic neu-
rons that functionally integrated into the endogenous
cholinergic projection system. These AD model mice with
grafted mouse or human BFCNs showed improved cogni-
tive abilities. Together, we develop a region- and subtype-
specific neural differentiation approach for both mouse
and human ESCs, and the neurons generated from this
approach ameliorate the cognitive symptoms of AD model
mice upon transplantation.
Region-Specific Differentiation from ESCs to BFCN
Progenitors
Pluripotent stem cells hold potential to give rise to region-
specific neural progenitors or functional neurons, and both
mouse and human ESCs have been widely studied to assess
their potential for ESC-based cell-replacement therapy for
neurodegenerative diseases. Dopaminergic neurons (Kim
et al., 2002; Kirkeby et al., 2012; Kriks et al., 2011; YangStem Cell Ret al., 2008), motor neurons (Harper et al., 2004;
Kim et al., 2002;Wichterle et al., 2002), GABAergic neurons
(Ma et al., 2012), and glutamatergic neurons (Eiraku et al.,
2008; Li et al., 2009) have also been generated from human
and mouse ESCs and demonstrated to be functional in
transgenic animal models related to different neurodegen-
erative diseases. However, the directed differentiation of
BFCNs from mouse ESCs has not yet been achieved. We
show here that cholinergic neurons with a basal forebrain
regional identity can be efficiently and rapidly derived
from mouse ESCs in a serum-free system. With sequential
treatment by SHH and BMP9, ChAT expression is robustly
induced and approximately 40% of total cells have become
ChAT+ neurons, whereas other neuron subtypes, such as
GABAergic, dopaminergic, and glutamatergic neurons,
are not significantly induced, indicating that this method
preferentially directs the differentiation of mouse ESCs
into cholinergic neurons. Further analysis showed that
the mouse ESC-derived cholinergic neurons are ISL1+/
NKX2.1+ and HB9, suggesting that they possess a basal
forebrain identity and are not motor neuron-like cells (Fig-
ure 1). Recent studies reported that human ESCs can differ-
entiate into BFCNs (Bissonnette et al., 2011; Liu et al.,eports j Vol. 5 j 776–790 j November 10, 2015 j ª2015 The Authors 787
2013). Bissonnette et al. (2011) showed that sequential
treatment with RA, SHH, and BMP9 can efficiently induce
the differentiation of human ESCs to BFCNs. It remained
unknown, however, whether early RA treatment estab-
lished a caudal positional identity or whether human
ESC-derived ChAT+ or VAChT+ neurons expressed basal
forebrain markers NKX2.1 or ISL1. Liu et al. (2013) showed
that a nearly uniform population of NKX2.1+ MGE-like
progenitors can be derived from human ESCs. These
MGE-like progenitors subsequently gave rise to equal
amounts of ChAT+ BFCNs (38% among TUJ1+ cells) and
GABAergic neurons (40% among TUJ1+ cells). Here, we
show that human ESCs can be predominantly differenti-
ated into BFCNs expressing VAChT, ChAT, NKX2.1, and
ISL1 and that other neuronal subtypes, including
GABAergic neurons, were not induced to the same extent
as BFCNs (Figure 5 and Figure S5). Together, these data indi-
cated that region- and subtype-specific differentiation from
both mouse and human ESCs to BFCNs has been success-
fully established.
Subtype-Specific Replacement and Functional
Integration by ESC-Derived BFCNs Ameliorate the
Cognitive Symptoms of AD Model Mice
Recently, multiple efforts have beenmade to relieve neuro-
pathological symptoms and restore cognitive function in
transgenic AD animal models using stem cell-based ap-
proaches. Astrocytes were transplanted into the hippocam-
pus of a transgenic ADmice and showed a capacity to inter-
nalize Ab deposits (Pihlaja et al., 2008). The hippocampal
transplantation of adult neural stem cell was reported to
induce the formation of new synapses and to rescue cogni-
tive deficits of AD mice without altering Ab deposits (Blur-
ton-Jones et al., 2009). The hippocampal transplantation
of human umbilical cord blood-derivedMSCs was reported
to rescuememory deficits in ADmice by reducing neuronal
apoptosis (Lee et al., 2010a). The same group reported that
bone marrow-derived MSCs could reduce Ab deposits and
rescue memory deficits in AD mice (Lee et al., 2010b).
The NBM transplantation of ESC-derived cholinergic pre-
cursors by SHH/RA treatment rescued memory deficits of
NBM-lesioned rats (Moghadam et al., 2009). Similarly, hu-
man iPSC-derived neuronal precursors by SHH/RA treat-
ment were shown to restore spatial memory of AD mice
upon hippocampal transplantation (Fujiwara et al.,
2013). The early and substantial degeneration of BFCNs
in AD patients is the key factor in cognitive deficits associ-
ated with the disease (Morrison and Hof, 1997), but it re-
mains unknown whether ESC-derived BFCNs can restore
cholinergic function and alleviate cognitive deficits in AD
model mice. In addition, the differentiation, migration,
or integration of grafted cells in the host brain was unclear.
In the present study, we successfully transplanted both788 Stem Cell Reports j Vol. 5 j 776–790 j November 10, 2015 j ª2015 Themouse and human ESC-derived BFCN progenitors into
the basal forebrain of transgenic AD model mice: 5XFAD
and APP/PS1. After the behavior test, the transplanted
mouse ESC-derived BFCN progenitors were demonstrated
to survive well and predominantly differentiate into
mature cholinergic neurons in the basal forebrain of host
mice (Figure 3 and Figure S6), suggesting that the grafted
BFCNprogenitors terminally differentiated into the correct
neuronal subtype with regional specificity. More impor-
tantly, the BFCN progenitor-derived cholinergic neurons
fired continuous APs, produced EPSCs and IPSCs in vivo,
and formed synapses with host neuron cells (Figures 4C
and 4D and Figure S4A), indicating that they functionally
integrated into the endogenous neuronal circuitry. These
cholinergic neurons also exhibited typical projection and
migration patterns along the host NBM and toward the
hippocampus (Figures 4E and 4F), indicating that they
morphologically incorporate into the endogenous basal
forebrain cholinergic projection system. In addition, the
ACh secretion and AChE activity increased in the brain of
5XFAD upon transplantation, indicating that the grafted
cell-derived cholinergic neurons functioned similarly to
their in vivo counterparts. The secretion of neurotrophic
factor BDNF also increased in the brain with grafted
BFCN progenitors, which is consistent with the previous
findings (Blurton-Jones et al., 2009). All these changes,
the integration of ESC-derived BFCNs and the increased
secretion of cholinergic transmitters or neurotrophic fac-
tor, in the host brain upon transplantation might synergis-
tically contribute to ameliorate the cognitive symptoms of
AD model mice.
Together, our findings demonstrate that bothmouse and
human ESCs efficiently differentiated into mature and
functional BFCNs and these ESC-derived BFCNs integrated
into the basal forebrain of AD mice and alleviated the
cognitive deficits of AD. These findings suggest that ESC-
derived BFCNs replacement and partial reconstruction of
damaged cholinergic neuron circuitry of AD model mice
might be possible, and they support the notion that stem
cell-based therapies could be developed to restore function
in the AD brain.EXPERIMENTAL PROCEDURES
Mouse and Human ESC Culture and Neural
Differentiation
Mouse ESC lines R1/E, E14, and CE3; human ESC line H9; and one
mouse iPSC line were maintained in standard medium supple-
mented with 10 ng/mL of leukemia inhibitory factor (Millipore)
for mouse ESCs and iPSCs and 8 ng/ml of fibroblast growth factor
(R&DSystems) for humanESCs. Subsequent steps in the neural dif-
ferentiation procedure are detailed in the Supplemental Experi-
mental Procedures.Authors
Immunofluorescence Staining
Immunocytochemistry staining on cell cultures was performed as
previously described. Additional details are included in the Supple-
mental Experimental Procedures.
Cell Transplantation
The animal experiments were carried out following protocols
approved by the Animal Ethics Committee of the Shanghai Insti-
tutes for Biological Sciences. Two strains of AD model mice,
5XFAD (Jackson No. 006554) and APP/PS1 (Jackson No. 004462),
were purchased from Jackson Laboratory. Subsequent steps in
the cell transplantationprocedure are detailed in the Supplemental
Experimental Procedures.
MWM Test
The MWM test was performed using hidden platform procedures
as described previously (Vorhees and Williams, 2006). For mouse
ESC-derived cells, the MWM test was performed 8 weeks after
transplantation and the training trials were conducted for 6 days.
For human ESC-derived cells, the MWM test was performed
6 weeks after transplantation and the training trials were conduct-
ed for 5 days.
Electrophysiology
Whole-cell patch-clamp recording was performed in mouse ESC-
derived neuron cells on differentiating days 15–16 (group I) or
days 20–22 (group II), mouse iPSC-derived neurons on day 18, hu-
man ESC-derived neurons on day 65, and EGFP+ BFCN progenitor-
derived neuron cells in the coronal brain slices of AD mice. The
whole-cell recordings were performed with Multiclamp 700B (Mo-
lecular Devices). Additional details are included in the Supple-
mental Experimental Procedures.
Statistical Analysis
Student’s t test (two-tailed) was performed for statistical analysis
between two groups. ANOVA tests were used when three or more
groups were compared. The statistical analyses were obtained
from three independent experiments. Statistical significance was
set at p < 0.05. All data are presented as the mean ± SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, and two tables and can be found with this
article online at http://dx.doi.org/10.1016/j.stemcr.2015.09.010.
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